Retinoblastoma-like protein 1 explained

Retinoblastoma-like 1 (p107), also known as RBL1, is a protein that in humans is encoded by the RBL1 gene.[1]

Function

The protein encoded by this gene is similar in sequence and possibly function to the product of the retinoblastoma 1 (RB1) gene. The RB1 gene product is a tumor suppressor protein that appears to be involved in cell cycle regulation, as it is phosphorylated in the S to M phase transition and is dephosphorylated in the G1 phase of the cell cycle. Both the RB1 protein and the product of this gene can form a complex with adenovirus E1A protein and SV40 Large T-antigen, with the SV40 large T-antigen binding only to the unphosphorylated form of each protein. In addition, both proteins can inhibit the transcription of cell cycle genes containing E2F binding sites in their promoters. Due to the sequence and biochemical similarities with the RB1 protein, it is thought that the protein encoded by this gene may also be a tumor suppressor. Two transcript variants encoding different isoforms have been found for this gene.[2]

Interactions

Retinoblastoma-like protein 1 has been shown to interact with:

See also

Further reading

Notes and References

  1. Ewen ME, Xing YG, Lawrence JB, Livingston DM . Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein . Cell . 66 . 6 . 1155–64 . Sep 1991 . 1833063 . 10.1016/0092-8674(91)90038-Z . 27478008 .
  2. Web site: Entrez Gene: RBL1 retinoblastoma-like 1 (p107).
  3. Fan S, Yuan R, Ma YX, Xiong J, Meng Q, Erdos M, Zhao JN, Goldberg ID, Pestell RG, Rosen EM . Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding . Oncogene . 20 . 35 . 4827–41 . Aug 2001 . 11521194 . 10.1038/sj.onc.1204666 . free .
  4. Sutcliffe JE, Cairns CA, McLees A, Allison SJ, Tosh K, White RJ . RNA polymerase III transcription factor IIIB is a target for repression by pocket proteins p107 and p130 . Molecular and Cellular Biology . 19 . 6 . 4255–61 . Jun 1999 . 10330166 . 104385 . 10.1128/mcb.19.6.4255.
  5. Joaquin M, Bessa M, Saville MK, Watson RJ . B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107 . Oncogene . 21 . 52 . 7923–32 . Nov 2002 . 12439743 . 10.1038/sj.onc.1206001 . 21761703 .
  6. Shanahan F, Seghezzi W, Parry D, Mahony D, Lees E . Cyclin E associates with BAF155 and BRG1, components of the mammalian SWI-SNF complex, and alters the ability of BRG1 to induce growth arrest . Molecular and Cellular Biology . 19 . 2 . 1460–9 . Feb 1999 . 9891079 . 116074 . 10.1128/mcb.19.2.1460.
  7. Leng X, Noble M, Adams PD, Qin J, Harper JW . Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4 . Molecular and Cellular Biology . 22 . 7 . 2242–54 . Apr 2002 . 11884610 . 133692 . 10.1128/mcb.22.7.2242-2254.2002.
  8. Dyson N, Dembski M, Fattaey A, Ngwu C, Ewen M, Helin K . Analysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1 . Journal of Virology . 67 . 12 . 7641–7 . Dec 1993 . 8230483 . 238233 . 10.1128/JVI.67.12.7641-7647.1993.
  9. Lai A, Lee JM, Yang WM, DeCaprio JA, Kaelin WG, Seto E, Branton PE . RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins . Molecular and Cellular Biology . 19 . 10 . 6632–41 . Oct 1999 . 10490602 . 84642 . 10.1128/mcb.19.10.6632.
  10. Ferreira R, Magnaghi-Jaulin L, Robin P, Harel-Bellan A, Trouche D . The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase . Proceedings of the National Academy of Sciences of the United States of America . 95 . 18 . 10493–8 . Sep 1998 . 9724731 . 27922 . 10.1073/pnas.95.18.10493. 1998PNAS...9510493F . free .
  11. Joaquin M, Watson RJ . The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain . The Journal of Biological Chemistry . 278 . 45 . 44255–64 . Nov 2003 . 12947099 . 10.1074/jbc.M308953200 . free .
  12. Chen CR, Kang Y, Siegel PM, Massagué J . E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression . Cell . 110 . 1 . 19–32 . Jul 2002 . 12150994 . 10.1016/s0092-8674(02)00801-2. 8945574 . free .
  13. Wang S, Nath N, Adlam M, Chellappan S . Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function . Oncogene . 18 . 23 . 3501–10 . Jun 1999 . 10376528 . 10.1038/sj.onc.1202684 . 33828482 .
  14. Fusco C, Reymond A, Zervos AS . Molecular cloning and characterization of a novel retinoblastoma-binding protein . Genomics . 51 . 3 . 351–8 . Aug 1998 . 9721205 . 10.1006/geno.1998.5368 .
  15. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M . Towards a proteome-scale map of the human protein-protein interaction network . Nature . 437 . 7062 . 1173–8 . Oct 2005 . 16189514 . 10.1038/nature04209 . 2005Natur.437.1173R . 4427026 .